TABLE A4.

Operation-Specific Details of Malignancy Type and Comorbidities

Characteristic	No. (%)
Total operations	988 (100)
Solid malignancy	738 (74.7)
Breast cancer	138 (14.0)
Colorectal cancer	92 (9.3)
Sarcoma	66 (6.7)
Brain cancer	48 (4.9)
Gastric cancer	47 (4.8)
Lung cancer	41 (4.1)
Ovarian cancer	39 (3.9)
Prostate cancer	34 (3.4)
Bladder cancer	26 (2.6)
Melanoma	20 (2.0)
Renal cell carcinoma	19 (1.9)
Cervical cancer	18 (1.8)
Uterine cancer	18 (1.8)
Head and neck cancer	17 (1.7)
Pancreatic cancer	14 (1.4)
Hepatocellular carcinoma	11 (1.1)
Squamous cell carcinoma	11 (1.1)
Appendiceal cancer	10 (1.0)
Cholangiocarcinoma	8 (0.8)
Esophageal cancer	8 (0.8)
Laryngeal cancer	8 (0.8)
Neuroendocrine tumor	7 (0.7)
Small bowel cancer	7 (0.7)
Others	31 (3.1)
Hematologic malignancy	250 (25.3)
AML	74 (7.5)
ALL	54 (5.5)
Myelodysplastic syndromes	35 (3.5)
Multiple myeloma	31 (3.1)
Diffuse large B-cell lymphoma	27 (2.7)
Chronic myeloid leukemia	9 (0.9)
Non-Hodgkin's lymphoma	8 (0.8)
Chronic lymphocytic leukemia	7 (0.7)
Others	5 (0.5)
Comorbidities
Hypertension, uncomplicated	236 (23.9)
Cardiac arrhythmias	202 (20.4)
Fluid and electrolyte disorders	156 (15.8)
Diabetes, uncomplicated	103 (10.4)
Liver disease	100 (10.1)
Coagulopathy	94 (9.5)
Depression	93 (9.4)
Hypothyroidism	84 (8.5)
Other neurologic disorders	81 (8.2)
Valvular disease	81 (8.2)
Diabetes, complicated	78 (7.9)
Obesity	71 (7.2)
Chronic pulmonary disease	68 (6.9)
Weight loss	47 (4.8)
Congestive heart failure	46 (4.7)
Renal failure	36 (3.6)
Deficiency anemias	33 (3.3)
Pulmonary circulation disorders	33 (3.3)
Peripheral vascular disorders	30 (3.0)
Rheumatoid arthritis/collagen vascular diseases	29 (2.9)
Hypertension, complicated	20 (2.0)
Paralysis	20 (2.0)
Blood loss anemia	17 (1.7)
Drug abuse	17 (1.7)
Peptic ulcer disease excluding bleeding	14 (1.4)
Alcohol abuse	8 (0.8)
Psychoses	6 (0.6)
AIDS/HIV	4 (0.4)